Impact of comorbidity on survival after surgical resection in patients with stage I non-small cell lung cancer.

Factors associated with decisions to undergo surgery among patients with newly diagnosed early-stage lung cancer. JAMA (2010) 2.99

Effect of comorbidity on the treatment and prognosis of elderly patients with non-small cell lung cancer. Thorax (2004) 2.77

The impact of comorbidity on cancer survival: a review. Clin Epidemiol (2013) 1.68

Pretreatment predictors of death from other causes in men with prostate cancer. J Urol (2008) 1.13

Risk factors for 30-day mortality after resection of lung cancer and prediction of their magnitude. Thorax (2007) 1.05

Surgical treatment of non-small-cell lung cancer in octogenarians. Interact Cardiovasc Thorac Surg (2013) 0.99

Influence of medical comorbidities on the presentation and outcomes of stage I-III non-small-cell lung cancer. Clin Lung Cancer (2013) 0.96

Decreased survival among lung cancer patients with co-morbid tuberculosis and diabetes. BMC Cancer (2012) 0.87

Previous tumour as a prognostic factor in stage I non-small cell lung cancer. Thorax (2006) 0.86

A comparison of comorbidities obtained from hospital administrative data and medical charts in older patients with pneumonia. BMC Health Serv Res (2011) 0.84

Impact of COPD in patients with lung cancer and advanced disease treated with chemotherapy and/or tyrosine kinase inhibitors. Int J Chron Obstruct Pulmon Dis (2014) 0.83

Impact of coexisting pulmonary diseases on survival of patients with lung adenocarcinoma: a STROBE-compliant article. Medicine (Baltimore) (2015) 0.82

Impact of comorbidity on lung cancer mortality - a report from the Liverpool Lung Project. Oncol Lett (2015) 0.80

Cardiovascular comorbidities and survival of lung cancer patients: Medicare data based analysis. Lung Cancer (2015) 0.80

Comorbidity and survival of Danish lung cancer patients from 2000-2011: a population-based cohort study. Clin Epidemiol (2013) 0.77

A Prognostic Model to Predict Mortality among Non-Small-Cell Lung Cancer Patients in the U.S. Military Health System. J Thorac Oncol (2015) 0.77

Impact of comorbidity on survival after surgical resection in patients with stage I non-small cell lung cancer. J Thorac Cardiovasc Surg (2003) 0.75

Impact of Lifestyle Diseases on Postoperative Complications and Survival in Elderly Patients with Stage I Non-Small Cell Lung Cancer. Korean J Thorac Cardiovasc Surg (2017) 0.75

Pre-existing Pulmonary Diseases and Survival in Patients With Stage-dependent Lung Adenocarcinoma: A STROBE-compliant Article. Medicine (Baltimore) (2016) 0.75

Amoxicillin for acute rhinosinusitis: a randomized controlled trial. JAMA (2012) 4.76

Persistent activation of an innate immune response translates respiratory viral infection into chronic lung disease. Nat Med (2008) 4.70

Small-airway obstruction and emphysema in chronic obstructive pulmonary disease. N Engl J Med (2011) 4.16

Morbidity and mortality of major pulmonary resections in patients with early-stage lung cancer: initial results of the randomized, prospective ACOSOG Z0030 trial. Ann Thorac Surg (2006) 3.76

Rhinosinusitis: establishing definitions for clinical research and patient care. J Allergy Clin Immunol (2004) 3.49

Mortality after prostate cancer treatment with radical prostatectomy, external-beam radiation therapy, or brachytherapy in men without comorbidity. Eur Urol (2013) 3.41

Video-assisted thoracoscopic lobectomy is less costly and morbid than open lobectomy: a retrospective multiinstitutional database analysis. Ann Thorac Surg (2011) 3.08

Quantitative in vivo assessment of lung microstructure at the alveolar level with hyperpolarized 3He diffusion MRI. Proc Natl Acad Sci U S A (2002) 2.96

Oct-4 expression maintained cancer stem-like properties in lung cancer-derived CD133-positive cells. PLoS One (2008) 2.90

Impact of immediate primary lung allograft dysfunction on bronchiolitis obliterans syndrome. Am J Respir Crit Care Med (2006) 2.69

Aldehyde dehydrogenase 1 is a putative marker for cancer stem cells in head and neck squamous cancer. Biochem Biophys Res Commun (2009) 2.57

Blocking airway mucous cell metaplasia by inhibiting EGFR antiapoptosis and IL-13 transdifferentiation signals. J Clin Invest (2006) 2.33

HLA alleles determine differences in human natural killer cell responsiveness and potency. Proc Natl Acad Sci U S A (2008) 2.31

IV delivery of induced pluripotent stem cells attenuates endotoxin-induced acute lung injury in mice. Chest (2011) 2.28

Survival among men with clinically localized prostate cancer treated with radical prostatectomy or radiation therapy in the prostate specific antigen era. J Urol (2012) 2.24

Late-onset driveline infections: the Achilles' heel of prolonged left ventricular assist device support. Ann Thorac Surg (2007) 2.22

Fatal thrombosis after administration of activated prothrombin complex concentrates in a patient supported by extracorporeal membrane oxygenation who had received activated recombinant factor VII. J Thorac Cardiovasc Surg (2002) 2.19

Stereotactic body radiation therapy versus surgical resection for stage I non-small cell lung cancer. J Thorac Cardiovasc Surg (2010) 2.06

Rhinosinusitis: Establishing definitions for clinical research and patient care. Otolaryngol Head Neck Surg (2004) 2.01

Quantification of lung microstructure with hyperpolarized 3He diffusion MRI. J Appl Physiol (1985) (2009) 2.01

Lung cancer screening. J Natl Compr Canc Netw (2012) 2.00

Respiratory viral infections are a distinct risk for bronchiolitis obliterans syndrome and death. Am J Respir Crit Care Med (2004) 1.95

De novo production of K-alpha1 tubulin-specific antibodies: role in chronic lung allograft rejection. J Immunol (2008) 1.95

Special treatment issues in lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition). Chest (2007) 1.94

Occult metastases in lymph nodes predict survival in resectable non-small-cell lung cancer: report of the ACOSOG Z0040 trial. J Clin Oncol (2011) 1.93

Differential prognostic impact of comorbidity. J Clin Oncol (2004) 1.92

The Chiari Severity Index: a preoperative grading system for Chiari malformation type 1. Neurosurgery (2015) 1.86

Alteration of DNA methyltransferases contributes to 5'CpG methylation and poor prognosis in lung cancer. Lung Cancer (2006) 1.82

Long-term outcome of bilateral lung volume reduction in 250 consecutive patients with emphysema. J Thorac Cardiovasc Surg (2003) 1.80

Non-Hodgkin's lymphoma presenting as a large chest wall mass. Ann Thorac Surg (2006) 1.77

Hyperpolarized 3He diffusion MRI and histology in pulmonary emphysema. Magn Reson Med (2006) 1.76

Antibodies to MHC class I induce autoimmunity: role in the pathogenesis of chronic rejection. J Immunol (2009) 1.74

The impact of the lung allocation score on short-term transplantation outcomes: a multicenter study. J Thorac Cardiovasc Surg (2007) 1.65

Cutting edge: Acute lung allograft rejection is independent of secondary lymphoid organs. J Immunol (2009) 1.64

Surgical results of synchronous multiple primary lung cancers: similar to the stage-matched solitary primary lung cancers? Ann Thorac Surg (2013) 1.64

Small cell carcinoma of the esophagus: a report of 16 cases from a single institution and literature review. Ann Thorac Surg (2011) 1.62

Murine vascular endothelium activates and induces the generation of allogeneic CD4+25+Foxp3+ regulatory T cells. J Immunol (2005) 1.61

The tobacco-specific carcinogen NNK induces DNA methyltransferase 1 accumulation and tumor suppressor gene hypermethylation in mice and lung cancer patients. J Clin Invest (2010) 1.57

Early posttransplant inflammation promotes the development of alloimmunity and chronic human lung allograft rejection. Transplantation (2007) 1.54

Potential for detrimental hyperinflation after lung transplantation with application of negative pleural pressure to undersized lung grafts. J Thorac Cardiovasc Surg (2003) 1.54

Sternoclavicular joint infection: a comparison of two surgical approaches. Ann Thorac Surg (2011) 1.52

Inhibition of nuclear factor kappaB by IkappaB superrepressor gene transfer ameliorates ischemia-reperfusion injury after experimental lung transplantation. J Thorac Cardiovasc Surg (2005) 1.52

Dysregulation of p53/Sp1 control leads to DNA methyltransferase-1 overexpression in lung cancer. Cancer Res (2010) 1.52

Benign esophageal tumors: introduction, incidence, classification, and clinical features. Semin Thorac Cardiovasc Surg (2003) 1.51

A prospective evaluation of lung volume reduction surgery in 200 consecutive patients. Chest (2003) 1.51

Preoperative serum carcinoembryonic antigen level is a prognostic factor in women with early non-small-cell lung cancer. Ann Thorac Surg (2007) 1.50

Risk factors for occult nodal metastasis in clinical T1N0 lung cancer: a negative impact on survival. Eur J Cardiothorac Surg (2008) 1.50

Benefits of resection for metachronous lung cancer. J Thorac Cardiovasc Surg (2004) 1.50

Anti-HLA class I antibody binding to airway epithelial cells induces production of fibrogenic growth factors and apoptotic cell death: a possible mechanism for bronchiolitis obliterans syndrome. Hum Immunol (2003) 1.50

Radial artery grafts in women: utilization and results. Ann Thorac Surg (2005) 1.48

Prevalence of benign disease in patients undergoing resection for suspected lung cancer. Ann Thorac Surg (2006) 1.46

Immunotargeting of catalase to the pulmonary endothelium alleviates oxidative stress and reduces acute lung transplantation injury. Nat Biotechnol (2003) 1.46

Pulmonary metastasectomy for hepatocellular carcinoma. J Chin Med Assoc (2004) 1.46

The significance of a single episode of minimal acute rejection after lung transplantation. Transplantation (2005) 1.46

Prognostic impact of comorbidity in patients with bladder cancer. Eur Urol (2007) 1.45

Gastric schwannoma. J Chin Med Assoc (2004) 1.44

The effect of ablation technology on surgical outcomes after the Cox-maze procedure: a propensity analysis. J Thorac Cardiovasc Surg (2007) 1.43

Long-term IL-33-producing epithelial progenitor cells in chronic obstructive lung disease. J Clin Invest (2013) 1.42

Significance of neurologic complications in the modern era of cardiac transplantation. Ann Thorac Surg (2007) 1.42

Anti-human leukocyte antigen antibodies and preemptive antibody-directed therapy after lung transplantation. J Heart Lung Transplant (2010) 1.41

Nonoperative management of large tracheal injuries. J Thorac Cardiovasc Surg (2008) 1.40

Results of lung volume reduction surgery in patients meeting a national emphysema treatment trial high-risk criterion. J Thorac Cardiovasc Surg (2004) 1.39

Unilateral hearing loss is associated with worse speech-language scores in children. Pediatrics (2010) 1.38

Alloimmunity-induced autoimmunity as a potential mechanism in the pathogenesis of chronic rejection of human lung allografts. J Heart Lung Transplant (2011) 1.37

Effect of formalin fixation on tumor size determination in stage I non-small cell lung cancer. Ann Thorac Surg (2007) 1.34

Outcomes after resection of giant emphysematous bullae. Ann Thorac Surg (2004) 1.33

Maintenance of airway epithelium in acutely rejected orthotopic vascularized mouse lung transplants. Am J Respir Cell Mol Biol (2007) 1.33

SLIT2 attenuation during lung cancer progression deregulates beta-catenin and E-cadherin and associates with poor prognosis. Cancer Res (2010) 1.33

Bronchial fenestration improves expiratory flow in emphysematous human lungs. Ann Thorac Surg (2003) 1.32

Antibodies to self-antigens predispose to primary lung allograft dysfunction and chronic rejection. Ann Thorac Surg (2010) 1.32

The epidemiology of bronchioloalveolar carcinoma over the past two decades: analysis of the SEER database. Lung Cancer (2004) 1.32

Induction of IL-10 suppressors in lung transplant patients by CD4+25+ regulatory T cells through CTLA-4 signaling. J Immunol (2006) 1.31

Minimal acute rejection after lung transplantation: a risk for bronchiolitis obliterans syndrome. Am J Transplant (2005) 1.31